Older patients with Crohn's disease benefit from new medications

Combining medications that suppress the immune system has been successful in treating young patients with Crohn's disease, but some physicians have been reluctant to use this strategy in older patients because of concerns about safety. Now an Alimentary Pharmacology & Therapeutics study indicates that older patients can be safely and effectively treated with such combined immunosuppression as well.

Among the 1,981 patients in the study, 311 were aged 60 years or older (173 randomised to early combined immunosuppression and 138 to conventional management). Over 24 months, 10 percent of older patients developed Crohn's disease?related complications (6.4 percent of those in the combined immunosuppression group versus 14.5 percent of those in the conventional management group) and 14 patients died (3.5 percent versus 5.8 percent).

Among the patients who received combined immunosuppression in the study, older patients experienced remission of their disease to a similar extent as those aged under 60 years. There was also no increase in side effects from these medicines in older patients.

"It is important to treat aggressive Crohn's appropriately regardless of age," said lead author Dr. Siddharth Singh, of the University of California San Diego. "This may include early step-up combination therapy of tumour necrosis factor-alpha antagonists with thiopurines, which is effective and safe even in , rather than treating these patients with chronic or repeated courses of corticosteroids."

More information: Siddharth Singh et al, Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT, Alimentary Pharmacology & Therapeutics (2019). DOI: 10.1111/apt.15214

Provided by Wiley
Citation: Older patients with Crohn's disease benefit from new medications (2019, March 20) retrieved 22 July 2024 from https://medicalxpress.com/news/2019-03-older-patients-crohn-disease-benefit.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Colorectal cancer in patients with early onset is distinct from that in older patients

 shares

Feedback to editors